Posted in General Business 30+ days ago.
Type: Full-Time
Location: Cambridge, Massachusetts
Sr. Financial Planning & Reporting Analyst, G&A
Overview
Alnylam is the world's leading RNA interference (RNAi) company.
Founded in 2002, Alnylam was built upon a bold vision of turning scientific possibility into reality by harnessing the power of RNAi for human health as an innovative new class of medicines. We are a growing biopharmaceutical company with three approved medicines and a robust pipeline of investigational medicines focused in four strategic therapeutic areas: genetic medicines, cardio-metabolic diseases, infectious diseases, and central nervous system (CNS) and ocular diseases, including several in late-stage development.
Headquartered in Cambridge, Mass., Alnylam employs over 1,500 people in 19 countries and is rapidly growing globally, with additional offices in Norton, Mass., Maidenhead, U.K., Zug, Switzerland, Amsterdam, Netherlands, and Tokyo, Japan. Alnylam is proud to have been recognized as one of The Boston Globe's Top Places to Work six years in a row (2015-2020), a Great Place to Work in the U.K. and Switzerland two years in a row (2019-2020) and a Science Magazine's Top Employer two years in a row (2019-2020). Please visit www.alnylam.com for more information.
Summary
Alnylam Pharmaceuticals is looking for a full time Sr. Financial Planning & Reporting Analyst to support G&A for one of Cambridge's most innovative, publicly traded biotech companies, focused on translating the science of siRNA into human therapies. Reporting to the Manager of G&A FP&A; the ideal candidate will be a detail-oriented, highly motivated professional with strong communication, organizational and computer skills.
Key Responsibilities
Key Requirements
Beacon Hill Staffing Group, LLC
|
INTERSYSTEMS CORPORATION
|
INTERSYSTEMS CORPORATION
|